e-learning
resources
Munich 2014
Sunday, 07.09.2014
Lung cell biology in injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES
F. Uhl, S. Vierkotten, G. Burgstaller, M. Lindner, O. Eickelberg, S. Meiners, M. Königshoff (Munich, Gauting, Germany)
Source:
International Congress 2014 – Lung cell biology in injury and repair
Session:
Lung cell biology in injury and repair
Session type:
Thematic Poster Session
Number:
874
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Uhl, S. Vierkotten, G. Burgstaller, M. Lindner, O. Eickelberg, S. Meiners, M. Königshoff (Munich, Gauting, Germany). LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES. Eur Respir J 2014; 44: Suppl. 58, 874
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
LATE-BREAKING ABSTRACT: PERSISTENTLY HIGH EXHALED NITRIC OXIDE AND LUNG FUNCTION DECLINE IN PATIENTS WITH CONTROLLED ASTHMA AT BASELINE
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
THE HUMAN LUNG: DID EVOLUTION GET IT WRONG?
Source: Eur Respir J 2007; 29: 823
Year: 2007
ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Late Breaking Abstract - ORAL FORMULATION OF ANGIOTENSIN-(1-7) PROMOTES RESOLUTION OF EOSINOPHILIC AND NEUTROPHILIC INFLAMMATION IN AN EXPERIMENTAL ASTHMA MODEL
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
DEFICIENT MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: ROLE OF SATELLITE CELLS
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019
LATE-BREAKING ABSTRACT: THE FATE OF INHALED DRUG: CORTICOSTEROID PARTICLE SIZE EFFECTS IN ASTHMA
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
PULMONARY REHABILITATION AFTER LUNG TRANSPLANTATION: DEVELOPMENT OF A PROTOCOL
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Late Breaking Abstract - SMOKING PREVALENCE AND CHARACTERIZATION OF PATIENTS AT DIAGNOSIS OF DIFFUSE INTERSTITIAL LUNG DISEASES
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
NOVEL KLF4-FOXO1 INTERACTOME IN LUNG FIBROBLASTS:REGULATOR OF MYOFIBROBLASTS IN HYPEROXIA-INDUCED LUNG INJURY
Source: Virtual Congress 2020 – Airway development in health and disease
Year: 2020
FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
THE PROGRESSION OF IMMUNE DISORDERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH CHANGES IN LEUKOCYTE MEMBRANE FATTY ACID COMPOSITION
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
HOME MONITORING WITH A PORTABLE OXYMETER AS AN ALTERNATIVE METHOD TO ASSESS OXYGEN SATURATION DURING DAILY ACTIVITIES IN INTERSTITIAL LUNG DISEASES (ILDs).
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
LUNG ADENOCARCINOMA: CLINICAL CHARACTERISTICS, MOLECULAR STUDY, DIAGNOSIS AND TREATMENT.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
EARLY DIAGNOSIS OF LUNG VENTILATION EVENNESS DISORDERS USING NONINVASIVE IMAGING
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept